Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Improved immunosuppression for heart transplantation.

R M Bolman, B Elick, M T Olivari

    The Journal of Heart Transplantation
    |May 1, 1985
    PubMed
    Summary

    A new immunosuppressive drug combination of cyclosporine, azathioprine, and prednisone effectively prevented rejection in heart transplant patients, even those with pre-existing kidney issues.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Making a difference: 5 years of Cardiac Surgery Intersociety Alliance (CSIA).

    Asian cardiovascular & thoracic annals·2024
    Same author

    Making a Difference: 5 Years of Cardiac Surgery Intersociety Alliance (CSIA).

    The Annals of thoracic surgery·2024
    Same author

    Making a difference: 5 years of Cardiac Surgery Intersociety Alliance (CSIA).

    The Journal of thoracic and cardiovascular surgery·2024
    Same author

    Making a difference: 5 years of Cardiac Surgery Intersociety Alliance (CSIA).

    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2024
    Same author

    Evaluating the Use of CT-Derived Lung Volumes in Donor-Recipient Lung Size Matching for Lung Transplantation in Patients With Interstitial Lung Disease and/or Idiopathic Pulmonary Fibrosis.

    Transplantation proceedings·2023
    Same author

    The Cape Town Declaration on Access to Cardiac Surgery in the Developing World.

    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2018

    Area of Science:

    • Immunology
    • Cardiology
    • Nephrology

    Background:

    • Cyclosporine has been the primary immunosuppressant for heart transplantation since 1981.
    • Concerns about cyclosporine's nephrotoxicity arose, particularly in patients with pre-existing renal insufficiency.

    Purpose of the Study:

    • To evaluate a modified immunosuppressive regimen for heart transplantation.
    • To assess the efficacy and safety of combining cyclosporine, azathioprine, and prednisone in heart transplant recipients.

    Main Methods:

    • A trial was initiated using a combination of cyclosporine, azathioprine, and prednisone for immunosuppression.
    • This regimen was tested in 17 heart transplant patients.

    Main Results:

    • The combination therapy demonstrated successful immunosuppression.
    • Patients experienced uncomplicated post-transplant courses.
    • Normal renal function was maintained in patients, including those with prior kidney issues.

    Conclusions:

    • The combination of cyclosporine, azathioprine, and prednisone provides effective immunosuppression for heart transplantation.
    • This regimen is a viable alternative, especially for patients at risk of nephrotoxicity.

    Related Experiment Videos